Improving Follow-Up of Abnormal Cancer Screening Results

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, OCTOBER 10, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.18755?guestAccessKey=e7a712fb-49f3-4095-97bf-4d9135a259e9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=101023

 

About The Study: A multilevel primary care intervention that included electronic health record reminders and patient outreach with or without patient navigation improved timely follow-up of overdue abnormal cancer screening test results for breast, cervical, colorectal, and lung cancer. 

Authors: Steven J. Atlas, M.D., M.P.H., of Massachusetts General Hospital in Boston, is the corresponding author.

 

(doi:10.1001/jama.2023.18755)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Educational Attainment and Drug Overdose Deaths

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2023.3274?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=100623

About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

Postsurgery Memory Impairment in Middle-Aged Chinese Patients

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, OCTOBER 10, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.36985?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=101023

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: This study of middle-aged Chinese surgery patients found subjective cognitive and short-term memory impairment within 12 months after both cardiac and noncardiac surgery, with multiple identified risk factors, underscoring the potential of preoperative psychological interventions and optimized perioperative management for postoperative cognitive impairment prevention.

Authors: Huan Song, M.D., Ph.D., and Qian Li, M.D., of Sichuan University in Chengdu, China, are the corresponding authors.

 

(doi: 10.1001/jamanetworkopen.2023.36985)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Brand Differences in Underage Tobacco Use as Evidence for Targeted Sanctions

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2023.3463?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=100623

About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

Use of Prenatal Telehealth in the First Year of the Pandemic

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, OCTOBER 10, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.37978?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=101023

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: This cross-sectional study found that most survey respondents who gave birth between June and December 2020 did not use prenatal telehealth, and a personal preference for in-person care was the most common reason. Patients’ preferences should influence how prenatal telehealth, which has both benefits and drawbacks, is incorporated into their care.

Authors: Rebecca A. Gourevitch, Ph.D., of the University of Maryland in College Park, is the corresponding author.

 

(doi: 10.1001/jamanetworkopen.2023.37978)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Patterns in Physician Burnout

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, OCTOBER 6, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.36745?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=100623

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: The findings of this survey study involving 1,373 physicians and three survey periods suggest that the physician burnout rate in the U.S. is increasing. This pattern represents a potential threat to the ability of the health care system to care for patients and needs urgent solutions. 

Authors: Marcus V. Ortega, M.D., of Massachusetts General Hospital in Boston, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2023.36745)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Autoimmune and Autoinflammatory Connective Tissue Disorders Following COVID-19

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, OCTOBER 6, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.36120?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=100623

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: COVID-19 was associated with a substantial risk for autoimmune and autoinflammatory connective tissue disorders in this retrospective cohort study, indicating that long-term management of patients with COVID-19 should include evaluation for such disorders. 

Authors: Solam Lee, M.D., Ph.D., of Yonsei University Wonju College of Medicine in Wonju, Republic of Korea, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2023.36120)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, OCTOBER 5, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.19574?guestAccessKey=31a6dd82-d1ee-46d6-b95e-e4ef621c2ddf&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=100523

 

About The Study: This study found that use of glucagon-like peptide-1 agonists for weight loss compared with use of bupropion-naltrexone was associated with increased risk of pancreatitis, gastroparesis, and bowel obstruction but not biliary disease. Given the wide use of these drugs, these adverse events, although rare, must be considered by patients who are contemplating using the drugs for weight loss because the risk-benefit calculus for this group might differ from that of those who use them for diabetes. 

Authors: Mahyar Etminan, Pharm.D., M.Sc., of the University of British Columbia in Vancouver, is the corresponding author.

 

(doi:10.1001/jama.2023.19574)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Racial and Ethnic Disparities in Glycemic Control Among Insured Adults

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, OCTOBER 5, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.36307?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=100523

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

  

About The Study: In this study of 4,070 insured adults with diabetes, disparities in poor glycemic control persisted despite adjustment for social, health care, and behavioral factors. Research is needed to identify the barriers contributing to poor control even in populations with access to care. 

Authors: Sandra S. Albrecht, Ph.D., M.P.H., of the Columbia University Mailman School of Public Health in New York, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2023.36307)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Generative AI for Chest Radiograph Interpretation in the Emergency Department

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, OCTOBER 5, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.36100?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=100523

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: In a representative sample of emergency department chest radiographs, results suggest that the generative artificial intelligence (AI) model produced reports of similar clinical accuracy and textual quality to radiologist reports while providing higher textual quality than teleradiologist reports. Implementation of the model in the clinical workflow could enable timely alerts to life-threatening pathology while aiding imaging interpretation and documentation. 

Authors: Mozziyar Etemadi, M.D., Ph.D., of Northwestern Medicine Information Services in Chicago, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2023.36100)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Changes in Cannabis-Attributable Hospitalizations Following Nonmedical Cannabis Legalization in Canada

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, OCTOBER 5, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.36113?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=100523

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: This study of 26.9 million individuals in four Canadian provinces found that cannabis legalization with restrictions was not associated with an increase in hospitalizations due to cannabis but commercialization was. The findings suggest that commercialization of cannabis may be associated with increases in cannabis-related health harms, including cannabis-induced psychosis. 

Authors: Daniel T. Myran, M.D., M.P.H., of the Ottawa Hospital Research Institute in Ottawa, Ontario, Canada, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2023.36113)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder Treatment

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2023.3596?guestAccessKey=8ae9f7c2-fd7c-4766-b7fb-feef9df270b3&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=100423

Pediatric RSV-Associated Hospitalizations Before and During the Pandemic

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, OCTOBER 4, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.36863?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=100423

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: This study found that the burden of respiratory syncytial virus (RSV)-associated hospitalizations in Canadian pediatric hospitals was substantial, particularly among infants less than six months of age, and RSV hospitalizations increased in 2021-2022 compared with the pre-pandemic period, while severity of illness remained similar. These findings suggest that RSV preventive strategies for infants less than six months of age would be associated with decreased RSV disease burden in children. 

Authors: Jesse Papenburg, M.D., M.Sc., of McGill University Health Centre in Montreal, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2023.36863)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Prevalence, Trends in Diagnosed ADHD Among Children and Adolescents

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, OCTOBER 4, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.36872?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=100423

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: Based on U.S. national representative data, the estimated attention-deficit hyperactivity disorder (ADHD) prevalence was 10.08% to 10.47% among children and adolescents ages 4 to 17 from 2017 to 2022, which was similar to the prevalence from the National Health Interview Survey in 2015 to 2016 (10.20%). No significant annual change in the prevalence of ADHD was found from 2017 to 2022. Notably, the estimated prevalence of ADHD among individuals in the U.S. in this study was higher than worldwide estimates (5.3%) in earlier years (1978-2005).

Authors: Wenhan Yang, M.D., Ph.D., of Guangdong Pharmaceutical University, and Jinhua Lu, M.M., of Guangzhou Medical University in Guangzhou, China, are the corresponding authors. 

 

(doi:10.1001/jamanetworkopen.2023.36872)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Effectiveness, Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease

JAMA Cardiology

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, OCTOBER 4, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2023.3364?guestAccessKey=bb07ae80-e9a3-46a8-95a7-faff2ca16b5a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=100423

 

About The Study: In this post hoc secondary analysis of 10,678 participants with atherosclerotic cardiovascular disease from a randomized clinical trial, enteric-coated aspirin was not associated with significantly higher risk of heart attack, stroke, or death or with lower bleeding risk compared with uncoated aspirin, regardless of dose, although a reduction in bleeding with enteric-coated aspirin cannot be excluded. More research is needed to confirm whether enteric-coated aspirin formulations or newer formulations will improve outcomes in this population.

Authors: Mark B. Effron, M.D., of the University of Queensland-Ochsner Clinical School in New Orleans, is the corresponding author.

 

(doi:10.1001/jamacardio.2023.3364)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes

JAMA

EMBARGOED FOR RELEASE: 3 A.M. (ET), TUESDAY, OCTOBER 3, 2023

Media advisory: The full study is linked to this news release. This study is being released to coincide with presentation at the European Association for the Study of Diabetes Annual Meeting 2023.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.20294?guestAccessKey=829f6242-2bbd-4685-b1cb-603307c596d0&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=100323

 

About The Study: In people with inadequately controlled type 2 diabetes treated with basal insulin in this randomized clinical trial with 1,428 participants, weekly tirzepatide compared with prandial insulin as an additional treatment with insulin glargine demonstrated reductions in HbA1c and body weight with less hypoglycemia. 

Authors: Julio Rosenstock, M.D., of Velocity Clinical Research at Medical City in Dallas, is the corresponding author.

 

(doi:10.1001/jama.2023.20294)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Early Metformin in Gestational Diabetes

JAMA

EMBARGOED FOR RELEASE: 3 A.M. (ET), TUESDAY, OCTOBER 3, 2023

Media advisory: The full study is linked to this news release. This study is being released to coincide with presentation at the European Association for the Study of Diabetes Annual Meeting 2023.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.19869?guestAccessKey=8568ea62-6457-41dc-8a4d-c197f621be42&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=100323

 

About The Study: In this randomized clinical trial, early treatment with metformin was not superior to placebo for the composite primary outcome of insulin initiation or a fasting glucose level of 5.1 mmol/L or greater at gestation weeks 32 or 38. Prespecified secondary outcome data support further investigation of metformin in larger clinical trials. 

Authors: Fidelma Dunne, Ph.D., of the University of Galway in Galway, Ireland, is the corresponding author.

 

(doi:10.1001/jama.2023.19869)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Disparities in Kidney Transplant Waitlisting Among Young Patients Without Medical Comorbidities

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2023.5013?guestAccessKey=6c327d9c-4a78-4abe-892c-b0f0b1bf59a4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=100223

Underlying Causes of TIA and Minor Ischemic Stroke and Risk of Major Vascular Events

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2023.3344?guestAccessKey=8746dfe4-f051-421d-9c6e-c4344c9ecaa5&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=100223

Persistence of Autism Spectrum Disorder From Early Childhood Through School Age

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2023.4003?guestAccessKey=ae5364d7-b15d-4c1e-b967-8cf62390baa8&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=100223

Accuracy and Reliability of Chatbot Responses to Physician Questions

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, OCTOBER 2, 2023

Media advisory: The full study and editorial are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.36483?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=100223

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: In this study including 33 physicians across 17 specialties who generated 284 medical questions, chatbot generated largely accurate information to diverse medical queries as judged by academic physician specialists with improvement over time, although it had important limitations. Further research and model development are needed to correct inaccuracies and for validation. 

Authors: Douglas B. Johnson, M.D., M.S.C.I., and Lee E. Wheless, M.D., Ph.D., of the Vanderbilt University Medical Center in Nashville, are the corresponding authors. 

 

(doi:10.1001/jamanetworkopen.2023.36483)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Paxlovid and COVID-19 Mortality and Hospitalization Among Patients With Vulnerability to COVID-19 Complications

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, OCTOBER 2, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.36678?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=100223

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: In this study of 6,866 individuals with COVID-19, nirmatrelvir and ritonavir (Paxlovid [Pfizer]) treatment was associated with reduced risk of COVID-19 hospitalization or death in clinically extremely vulnerable individuals, with the greatest benefit observed in severely immunocompromised individuals. No reduction in the primary outcome (death from any cause or emergency hospitalization with COVID-19 within 28 days) was observed in lower-risk individuals, including those age 70 or older without serious comorbidities. 

Authors: Colin R. Dormuth, Sc.D., of the University of British Columbia in Vancouver, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2023.36678)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Loneliness and Risk of Parkinson Disease

JAMA Neurology

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, OCTOBER 2, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2023.3382?guestAccessKey=be4c71ac-6088-46a4-8e8d-ab107159961a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=100223

 

About The Study: This study of 491,000 participants followed up for up to 15 years found that loneliness was associated with risk of incident Parkinson disease across demographic groups and independent of depression and other prominent risk factors and genetic risk. The findings add to the evidence that loneliness is a substantial psychosocial determinant of health.

Authors: Antonio Terracciano, Ph.D., of the Florida State University College of Medicine in Tallahassee, is the corresponding author.

 

(doi:10.1001/jamaneurol.2023.3382)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Adherence to CPAP Treatment and the Risk of Recurrent Cardiovascular Events

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, OCTOBER 3, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.17465?guestAccessKey=10a08cfc-72c2-4070-9e65-9dc93d0f35ad&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=100323

 

About The Study: The results of this meta-analysis indicate that adherence to continuous positive airway pressure (CPAP) was associated with a reduced major adverse cardiac and cerebrovascular event recurrence risk, suggesting that treatment adherence is a key factor in secondary cardiovascular prevention in patients with obstructive sleep apnea.

Authors: Ferran Barbé, M.D., of the Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES) in Madrid, is the corresponding author.

 

(doi:10.1001/jama.2023.17465)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

 

Use of Electronic Clinical Data to Track Incidence and Mortality for SARS-CoV-2–Associated Sepsis

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, SEPTEMBER 29, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.35728?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=092923

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: The results of this study of 431,000 inpatient encounters at five Massachusetts hospitals suggest that SARS-CoV-2–associated sepsis was common and had higher mortality than presumed bacterial sepsis early in the COVID-19 pandemic. These findings highlight the high burden of SARS-CoV-2–associated sepsis and demonstrate the utility of electronic health record-based algorithms to conduct surveillance for viral and bacterial sepsis. 

Authors: Claire N. Shappell, M.D., M.P.H., of Brigham and Women’s Hospital in Boston, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2023.35728)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Neighborhood Factors, Individual Stressors, and Cardiovascular Health Among Black and White Adults

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, SEPTEMBER 29, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.36207?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=092923

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: In this study of Black and white U.S. adults ages 45 and older, neighborhood-level factors, including safety and physical and social environments, and individual-level factors, including discrimination, attenuated racial disparities in cardiovascular health. Interventional approaches to improve ideal cardiovascular health that separately target neighborhood context and discrimination by gender and race are warranted. 

Authors: Anika L. Hines, Ph.D., M.P.H., of the Virginia Commonwealth University School of Medicine in Richmond, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2023.36207)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Psychotropic Medication Use in Children and Adolescents With Type 1 Diabetes

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, OCTOBER 3, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.36621?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=100323

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: This study found an increasing trend in psychotropic medication dispensation among Swedish children and adolescents with type 1 diabetes from 2006 to 2019, persistently higher than those without type 1 diabetes. These findings call for further in-depth investigations into the benefits and risks of psychotropic medications within this population and highlight the importance of integrating pediatric diabetes care and mental health care for early detection of psychological needs and careful monitoring of medication use.

Authors: Shengxin Liu, M.Sc., of the Karolinska Institutet in Solna, Sweden is the corresponding author.

 

(doi: 10.1001/jamanetworkopen.2023.36621)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Utilization and Spending on Mental Health Services Among Children and Youths With Commercial Insurance

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, OCTOBER 3, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.36979?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=100323

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: After comparing mental health care service utilization and spending rates for children and youths with commercial insurance across three periods from January 2019 through August 2022, this study found differences between periods as well as different rates of change within each period for both visit types (in-person and telehealth), even after accounting for state and patient sex. Utilization and spending increased over the entire timeframe. Attention-deficit/hyperactivity disorder, anxiety disorders, and adjustment disorder accounted for most visits and spending in all phases.

Authors: Mariah M. Kalmin, Ph.D., of the RAND Corporation in Santa Monica, California is the corresponding author.

 

(doi: 10.1001/jamanetworkopen.2023.36979)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Misinformation, Trust, and Use of Ivermectin and Hydroxychloroquine for COVID-19

JAMA Health Forum

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, SEPTEMBER 29, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2023.3257?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=092923

About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

 

About The Study: In this 50-state survey study of 13,438 adults who reported probable or definite COVID-19 infection, endorsement of misinformation about the COVID-19 pandemic, lack of trust in physicians or scientists, conspiracy-mindedness, and the nature of news sources were associated with receiving non–evidence-based treatment for COVID-19. These results suggest that the potential harms of misinformation may extend to the use of ineffective and potentially toxic treatments in addition to avoidance of health-promoting behaviors. 

Authors: Roy H. Perlis, M.D., M.Sc., of Massachusetts General Hospital in Boston, is the corresponding author.

 

(doi:10.1001/jamahealthforum.2023.3257)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Virtual Tumor Board to Foster Interinstitutional Head and Neck Cancer Subspecialty Care

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/10.1001/jamaoto.2023.1941?guestAccessKey=ae2612d6-a3a4-4926-8363-c16924171b80&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=092823

Pharmacist-Led Diabetes Control Intervention and Health Outcomes in Hispanic Patients With Diabetes

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 28, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.35409?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=092823

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: The results of this study that included 931 Hispanic adults suggest that a pharmacist-led intervention may be a strategy for improving some outcomes among Hispanic patients with type 2 diabetes. 

Authors: Kimberly Danae Cauley Narain, M.D., Ph.D., M.P.H., of the University of California, Los Angeles, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2023.35409)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Developing an Electroencephalography-Based Model for Predicting Response to Antidepressant Medication

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 28, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.36094?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=092823

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: The findings of this study suggest that the use of electroencephalography can provide a reliable method for predicting response to specific antidepressant medications and may help match patients with depression to optimized treatment. 

Authors: Faranak Farzan, Ph.D., of Simon Fraser University in Surrey, British Columbia, Canada, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2023.36094)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Barriers to Care Among Sexual and Gender Minority Individuals With Chronic Inflammatory Skin Diseases

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2023.3328?guestAccessKey=f02c5664-5e88-48fe-8157-67c4e7799d2b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=092723

Antidepressant Use and Risk of Manic Episodes in Children and Adolescents With Unipolar Depression

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2023.3555?guestAccessKey=a528f1ff-c9bb-4636-9315-1e51ff0a50f9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=092723

One-Year Association of Drug Possession Law Change With Fatal Drug Overdose in Oregon and Washington

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2023.3416?guestAccessKey=102781ce-e0e7-4adf-a70b-c49bbe1335e2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=092723

Cannabis Use Frequency and Cannabis-Related Consequences in High-Risk Young Adults Across Cannabis Legalization

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, SEPTEMBER 27, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.36035?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=092723

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: In a study of 619 high-risk young adults in Ontario, Canada, individuals using cannabis frequently pre-legalization showed significant reductions in use and consequences over time, reflecting an aging out pattern. Small increases in use among participants with no pre-legalization use were observed over time, but without parallel changes in cannabis-related consequences. The results did not reveal substantive adverse near-term outcomes across the legalization period, although a within-participants design cannot rule out the possibility of alternative trajectories in the absence of legalization. 

Authors: Amanda Doggett, Ph.D., of McMaster University/St. Joseph’s Healthcare in Hamilton, Ontario, Canada, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2023.36035)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Community Mobility and Depressive Symptoms During the Pandemic

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, SEPTEMBER 27, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.34945?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=092723

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: Depressive symptoms were greater in locales and times with diminished community mobility in this survey study with 192,000 respondents. Strategies to understand the potential public health consequences of pandemic responses are needed. 

Authors: Roy H. Perlis, M.D., M.Sc., of Massachusetts General Hospital in Boston, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2023.34945)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Mental Health Symptoms in Oral Contraceptive Users During Short-Term Hormone Withdrawal

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, SEPTEMBER 27, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.35957?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=092723

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: In this study of long-term combined oral contraceptive users, withdrawal from contraceptive steroids during the pill pause (short-term hormone withdrawal) was associated with adverse mental health symptoms similar to those experienced by women during menses with withdrawal from endogenous steroids. These results question the use of the pill pause from a mental health perspective. 

Authors: Belinda Pletzer, Ph.D., of the University of Salzburg in Salzburg, Austria, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2023.35957)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Changes in Diagnoses and Site of Care for Patients Receiving Hospice Care From Agencies Acquired by Private Equity Firms and Publicly Traded Companies

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.34582?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=092523

Childhood and Adolescence Gender Role Nonconformity and Gender and Sexuality Diversity in Young Adulthood

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2023.3873?guestAccessKey=69771c64-e69b-47a9-90c2-651a2bc42eb6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=092523

Racial, Ethnic, and Sex Diversity in Academic Medical Leadership

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, SEPTEMBER 25, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.35529?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=092523

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

  

About The Study: The results of this study suggest that select specialties in academic medicine have bridged diversity gaps in academic medical leadership whereas others continue to lag behind.

Authors: Charles S. Day, M.D., M.B.A., of Henry Ford Health in Detroit, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2023.35529)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Racial Disparities in Emergency Department Physical Restraint Use

JAMA Internal Medicine

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, SEPTEMBER 25, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2023.4832?guestAccessKey=b98abc6b-4af6-4e47-8214-d22b1fe1de06&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=092523

 

About The Study: In this systematic review and meta-analysis of 10 studies, physical restraint was uncommon, occurring in less than 1% of encounters, but adult Black patients experienced a significantly higher risk of physical restraint in emergency department settings compared with other racial groups. Emergency departments should carefully consider, and take steps to address, how racism may affect disparate use of restraints among adult patients. 

Authors: Vidya Eswaran, M.D., of the Baylor College of Medicine in Houston, is the corresponding author.

 

(doi:10.1001/jamainternmed.2023.4832)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Access to Marijuana by Minors Via Online Dispensaries

JAMA Pediatrics

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, SEPTEMBER 25, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2023.3656?guestAccessKey=2336beb9-6ab9-4337-a431-d9d6ac32adc9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=092523

 

About The Study: This analysis of 80 online marijuana dispensaries based in 32 states found that most lacked adequate age verification features and most accepted nontraceable payment methods, enabling youth to hide their transactions. Almost 1 in 5 online dispensaries required no formal age verification at any stage of the purchasing process. 

Authors: Ruth L. Milanaik, D.O., of Steven and Alexandra Cohen Children’s Medical Center of New York in Lake Success, is the corresponding author.

 

(doi:10.1001/jamapediatrics.2023.3656)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Premorbid Sociodemographic Status and Multiple Sclerosis Outcomes With Universal Health Care

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, SEPTEMBER 26, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.34675?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=092623

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: In this study of working-age adults with multiple sclerosis (MS), premorbid income, education, and marital status correlated with disability and symptom severity in relapse onset and progressive-onset MS, independent of treatment. These findings suggest that socioeconomic status may reflect both structural and individual determinants of health in MS.

Authors: Anna He, M.B.B.S., of the Karolinska Institute in Stockholm, Sweden is the corresponding author.

 

(doi: 10.1001/jamanetworkopen.2023.34675)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Alcohol Use and Sustained Virologic Response to Hepatitis C Virus Direct-Acting Antiviral Therapy

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, SEPTEMBER 26, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.35715?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=092623

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: In this study of 69,000 adults with hepatitis C virus (HCV) infection, there was no difference in sustained virologic response across alcohol use categories, even for patients with high-risk consumption or alcohol use disorder, after adjusting for potential confounding variables. These findings suggest that restricting access to direct-acting antiviral therapy on the basis of alcohol use creates an unnecessary barrier for patients and challenges HCV elimination goals.

Authors: Emily J. Cartwright, M.D., of the Emory University School of Medicine in Atlanta, and Christopher T. Rentsch, Ph.D., of the London School of Hygiene & Tropical Medicine in London, are the corresponding authors.

 

(doi: 10.1001/jamanetworkopen.2023.35715)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Suicide Risks of Health Care Workers in the US

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, SEPTEMBER 26, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.15787?guestAccessKey=1d868b3c-4f85-4cc1-ace7-d74f046bcc87&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=092623

 

About The Study: From a nationally representative cohort of approximately 1.84 million employed adults observed from 2008 through 2019, relative to non–health care workers, registered nurses, health technicians, and health care support workers in the U.S. were at increased risk of suicide. New programmatic efforts are needed to protect the mental health of these U.S. health care workers.

Authors: Mark Olfson, M.D., M.P.H., of Columbia University in New York, is the corresponding author.

 

(doi:10.1001/jama.2023.15787)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Impairment and Disability Identity and Perceptions of Trust, Respect, and Fairness

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2023.3180?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=092223

About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

Medicaid Value-Based Payments and Health Care Use for Patients With Mental Illness

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2023.3197?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=092223

About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

Vulnerability of Older Adults to Government Impersonation Scams

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, SEPTEMBER 22, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.35319?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=092223

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: In this study using a behavioral experiment designed to mimic a real-world imposter scam among 644 older adults, a sizable number of older adults engaged without skepticism. The results suggest that many older adults, including those without cognitive impairment, are vulnerable to fraud and scams. 

Authors: Lei Yu, Ph.D., of Rush University Medical Center in Chicago, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2023.35319)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Cardiovascular Disease Burden, Outcomes Among American Indian and Alaska Native Medicare Beneficiaries

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, SEPTEMBER 22, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.34923?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=092223

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: The results of this study of 220,000 American Indian and Alaska Native patients with Medicare insurance suggest a significant burden of cardiovascular disease and cardiometabolic risk factors. These findings highlight the critical need for future efforts to prioritize the cardiovascular health of this population. 

Authors: Lauren A. Eberly, M.D., M.P.H., of the Indian Health Service in Gallup, New Mexico, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2023.34923)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Paxlovid or Lagevrio Use and Severe Outcomes From Omicron Infections

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 21, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.35077?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=092123

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: The findings of this study of 68,000 patients who received a diagnosis of COVID-19 and who were at high risk of progressing to severe COVID-19 suggest that the use of either nirmatrelvir (Paxlovid) or molnupiravir (Lagevrio) is associated with reductions in mortality and hospitalization in patients infected with Omicron, regardless of age, race and ethnicity, virus strain, vaccination status, previous infection status, or coexisting conditions. Both drugs can, therefore, be used to treat non-hospitalized patients who are at high risk of progressing to severe COVID-19. 

Authors: Dan-Yu Lin, Ph.D., of the University of North Carolina in Chapel Hill, and Xiaofeng Wang, Ph.D., of the Cleveland Clinic, are the corresponding authors. 

 

(doi:10.1001/jamanetworkopen.2023.35077)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Incidence of Diabetes Among Youth Before and During the Pandemic

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 21, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.34953?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=092123

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: In this study that included data from Kaiser Permanente Southern California of individuals age 19 and younger, the incidence of type 1 diabetes slightly increased overall and type 2 diabetes significantly increased after the beginning of the COVID-19 pandemic, in particular among non-Hispanic Black and Hispanic youth. These findings suggest the need for further evaluation of physiologic and behavioral risk factors preceding new-onset diabetes during the pandemic. 

Authors: Matthew T. Mefford, Ph.D., of Kaiser Permanente Southern California in Pasadena, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2023.34953)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Disparities in Emergency Medicine Residents’ Performance Assessments by Race, Ethnicity, and Sex

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 21, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.30847?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=092123

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: This analysis of assessments of 2,708 emergency medicine residents found evidence of sex-specific ethnoracial disparities in ratings on the Milestones assessments. These disparities increased over time across multiple Milestones assessments and were most severe for female residents of ethnoracial groups that are underrepresented in medicine. 

Authors: Elle Lett, Ph.D., M.A., M.Biostat., of the University of Washington School of Public Health in Seattle, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2023.30847)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Prenatal Exposure to Nonpersistent Environmental Chemicals and Postpartum Depression

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2023.3542?guestAccessKey=b4a57432-dd49-410b-9e0e-9e6a71921e32&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=092023

Consumption of Ultraprocessed Food and Risk of Depression

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, SEPTEMBER 20, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.34770?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=092023

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: The findings of this study suggest that greater ultraprocessed food (UPF; i.e., energy-dense, palatable, and ready-to-eat items) intake, particularly artificial sweeteners and artificially sweetened beverages, is associated with increased risk of depression. Although the mechanism associating UPF to depression is unknown, recent experimental data suggests that artificial sweeteners elicit purinergic transmission in the brain, which may be involved in the etiopathogenesis of depression. 

Authors: Raaj S. Mehta, M.D., M.P.H., and Andrew T. Chan, M.D., M.P.H., of Massachusetts General Hospital and Harvard Medical School in Boston, are corresponding authors. 

 

(doi:10.1001/jamanetworkopen.2023.34770)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.